Point72 Asset Management, L.P. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$14,144,000
-26.8%
355,100
-31.6%
0.06%
-34.1%
Q3 2021$19,327,000
-31.2%
519,400
-21.8%
0.08%
-32.5%
Q2 2021$28,072,000
+833.6%
664,115
+945.7%
0.13%
+800.0%
Q1 2021$3,007,000
-94.8%
63,509
-93.3%
0.01%
-95.0%
Q4 2020$57,795,000
+12.8%
947,000
-13.6%
0.28%
+7.6%
Q3 2020$51,230,000
-34.9%
1,095,829
-29.4%
0.26%
-49.0%
Q2 2020$78,737,000
+22.5%
1,551,774
+7.7%
0.51%
-1.5%
Q1 2020$64,266,000
-18.7%
1,440,600
-12.5%
0.52%
+25.5%
Q4 2019$79,043,000
-16.2%
1,645,701
-41.0%
0.42%
-28.2%
Q3 2019$94,311,000
-21.0%
2,788,607
+5.1%
0.58%
-7.2%
Q2 2019$119,360,000
+9.1%
2,652,447
-8.7%
0.62%
+25.8%
Q1 2019$109,359,000
+117.5%
2,905,393
+98.3%
0.50%
+102.4%
Q4 2018$50,273,000
+1103.3%
1,464,817
+1547.7%
0.24%
+1341.2%
Q3 2018$4,178,000
-47.8%
88,900
-77.8%
0.02%
-52.8%
Q3 2017$8,004,000
+1744.2%
400,000
+1587.8%
0.04%
+1700.0%
Q2 2017$434,000
-94.8%
23,700
-97.2%
0.00%
-95.7%
Q1 2017$8,371,000
+5753.8%
850,698
+8240.2%
0.05%
+4500.0%
Q3 2016$143,000
-99.2%
10,200
-98.5%
0.00%
-99.3%
Q3 2015$18,071,000
+140.2%
676,800
+333.0%
0.14%
+171.2%
Q2 2015$7,523,000
-14.0%
156,300
-7.5%
0.05%
-14.8%
Q4 2014$8,749,000
+27.0%
169,000
+8.0%
0.06%
+17.3%
Q3 2014$6,888,000156,5000.05%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders